Resar L, Luo L
Int J Mol Sci. 2025; 26(5).
PMID: 40076747
PMC: 11899949.
DOI: 10.3390/ijms26052125.
Zhong Q, Zhao B, She X, Liu X
PLoS One. 2024; 19(11):e0311204.
PMID: 39591457
PMC: 11594397.
DOI: 10.1371/journal.pone.0311204.
Khazem F, Zetoune A
Discov Oncol. 2024; 15(1):322.
PMID: 39085703
PMC: 11291832.
DOI: 10.1007/s12672-024-01202-x.
Chikhirzhina E, Tsimokha A, Tomilin A, Polyanichko A
Int J Mol Sci. 2024; 25(14).
PMID: 39062899
PMC: 11276821.
DOI: 10.3390/ijms25147656.
Guo J, He K, Yuan J, An W, Yin W, Li Q
Int J Biol Sci. 2024; 20(7):2640-2657.
PMID: 38725843
PMC: 11077367.
DOI: 10.7150/ijbs.95595.
House of CarDs: Functional insights into the transcriptional regulator CdnL.
Smith E, Goley E
Mol Microbiol. 2024; 122(5):789-796.
PMID: 38664995
PMC: 11502505.
DOI: 10.1111/mmi.15268.
Triggering receptor expressed on myeloid cells-1 in sepsis, and current insights into clinical studies.
Theobald V, Schmitt F, Middel C, Gaissmaier L, Brenner T, Weigand M
Crit Care. 2024; 28(1):17.
PMID: 38191420
PMC: 10775509.
DOI: 10.1186/s13054-024-04798-2.
Insight into the function of tetranectin in human diseases: A review and prospects for tetranectin-targeted disease treatment.
Iram S, Rahman S, Choi I, Kim J
Heliyon. 2024; 10(1):e23512.
PMID: 38187250
PMC: 10770464.
DOI: 10.1016/j.heliyon.2023.e23512.
The pathogenesis and potential therapeutic targets in sepsis.
Zhang W, Jiang H, Wu G, Huang P, Wang H, An H
MedComm (2020). 2023; 4(6):e418.
PMID: 38020710
PMC: 10661353.
DOI: 10.1002/mco2.418.
Extracellular Leakage Protein Patterns in Two Types of Cancer Cell Death: Necrosis and Apoptosis.
Sato A, Shimotsuma A, Miyoshi T, Takahashi Y, Funayama N, Ogino Y
ACS Omega. 2023; 8(28):25059-25065.
PMID: 37483236
PMC: 10357420.
DOI: 10.1021/acsomega.3c01691.
A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis.
Li J, Zhu C, He L, Qiang X, Chen W, Wang H
Expert Opin Ther Targets. 2023; 27(7):575-591.
PMID: 37477229
PMC: 10530501.
DOI: 10.1080/14728222.2023.2239495.
DNA-binding proteins studied by mechanical manipulation and AFM imaging of single DNA molecules.
Zhao X, Liu X, Yan J
Biophys Rep. 2023; 8(4):212-224.
PMID: 37288005
PMC: 10185484.
DOI: 10.52601/bpr.2022.220015.
Structure and Functions of HMGB2 Protein.
Starkova T, Polyanichko A, Tomilin A, Chikhirzhina E
Int J Mol Sci. 2023; 24(9).
PMID: 37176041
PMC: 10179549.
DOI: 10.3390/ijms24098334.
Immunogenic cell death in cancer immunotherapy.
Choi M, Shin J, Lee C, Chung J, Kim M, Yan X
BMB Rep. 2023; 56(5):275-286.
PMID: 37081756
PMC: 10230015.
HMGB1, angel or devil, in ischemic stroke.
Gao B, Wang S, Li J, Han N, Ge H, Zhang G
Brain Behav. 2023; 13(5):e2987.
PMID: 37062906
PMC: 10176004.
DOI: 10.1002/brb3.2987.
Structural Characteristics of High-Mobility Group Proteins HMGB1 and HMGB2 and Their Interaction with DNA.
Starkova T, Polyanichko A, Artamonova T, Tsimokha A, Tomilin A, Chikhirzhina E
Int J Mol Sci. 2023; 24(4).
PMID: 36834988
PMC: 9962726.
DOI: 10.3390/ijms24043577.
The regulation and function of acetylated high-mobility group box 1 during implantation and decidualization.
Li Y, Chen S, He Y, Li B, Yang C, Yang Z
Front Immunol. 2023; 14:1024706.
PMID: 36761729
PMC: 9905834.
DOI: 10.3389/fimmu.2023.1024706.
Targeting of Hmo1 to subcompartments of the budding yeast nucleolus.
Girke P, Seufert W
Mol Biol Cell. 2023; 34(3):ar22.
PMID: 36696177
PMC: 10011721.
DOI: 10.1091/mbc.E22-07-0261.
The Role of PARP1 and PAR in ATP-Independent Nucleosome Reorganisation during the DNA Damage Response.
Belousova E, Lavrik O
Genes (Basel). 2023; 14(1).
PMID: 36672853
PMC: 9859207.
DOI: 10.3390/genes14010112.
Regulation of HMGB1 Release in Health and Diseases.
Wang H
Cells. 2023; 12(1).
PMID: 36611839
PMC: 9818800.
DOI: 10.3390/cells12010046.